Study ID: TV1106-IMM-20001 | 2013-004468-69
Study Title
- A Phase 2, Safety and Dose-Finding Study in Treatment-Naive, Pre-Pubertal, Growth Hormone-Deficient Children
Teva Identifier
- TV1106-IMM-20001 | 2013-004468-69
ClinicalTrials.gov Identifier
- NCT02092077
Study Status
- Terminated
Trial Condition(s)
- Growth Hormone-Deficiency
Interventions
- Drug: TV-1106 | Drug: somatropin
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial

Key Participation Requirements
Gender
- Female, Male
Age Range
- 3 Years to 11 Years
Trial Duration
- April 30, 2014 - August 31, 2016
Phase
- Phase 2
Study Type
Interventional